13th Vaccine Congress

Organizers from Elsevier’s journal Vaccine will host the 13th Vaccine Congress 15-18 September 2019 in Bangkok, Thailand.

The congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field.

Agenda topics of interest highlighted by the Global Biodefense staff include:

• Insertion-responsive microneedles for rapid intradermal delivery of influenza vaccine
• Immunogenicity of virus-like particle (VLP)-based coronavirus vaccines
• A brief review of adversomics: understanding genetic drivers for adverse events after vaccination
• Developing a novel, safe and effective platform for generating flavivirus vaccines
• Novel adenoviral vector platform for developing a universal influenza vaccine
• Chicken IFITM knockout technology for increased vaccine production
• The role of the microbiome in host interactions and vaccine responses
• Optimized recombinant Newcastle disease virus expressing the F protein of respiratory syncytial virus has improved antigen expression levels and immunogenicity
• Identification of immunostimulatory domains of flagellin for better adjuvant design
• Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
• Development of bat stem cell lines by somatic reprogramming to study bat-derived
  highly pathogenic viruses
• Vaccination with 1/6th standard dose of a split inactivated influenza vaccine using the Nanopatch™
  induces comparable immune responses to conventional full-dose intramuscular injection
• Mucosal immunity in therapeutic and prophylactic vaccine trials
• Translating the intestinal microbiome for oral vaccine performance
• Neuraminidase-based influenza virus vaccines
• Assessment of outer membrane vesicles derived from Escherichia coli Nissle 1917as a novel mucosal adjuvant in intranasal inactivated influenza vaccine
• Enhancing Chikungunya Virus Immunity By Improved Vaccination
• Pre-clinical protective efficacy of a VLP-based vaccine against Zika virus
• Needle Adapters and Needle-free Injectors for Intradermal Administration of Fractional Dose of
  Inactivated Poliovirus Vaccine

Please visit the 13th Vaccine Congress website for more information and to register for the event.